A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants

Clinical trial NCT06982131 · RECRUITING

Trial details

NCT number: NCT06982131
Sponsor: Hoffmann-La Roche
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight Obesity

Start date: 2025-06-04
Primary completion: 2026-12-04
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.